VIDEO: Seladelpar may improve transplant-free survival in primary biliary cholangitis

In a Healio video exclusive, Bettina E. Hansen, MSc, PhD, discusses improvement in transplant-free survival in patients treated with seladelpar for primary biliary cholangitis.Hansen and colleagues conducted a long-term, open-label study and used the GLOBE score, a risk assessment tool, to determine the effect of oral seladelpar on transplant-free survival in patients with PBC.“We were able to estimate an improved GLOBE score over time for 2 years,” Hansen, a senior biostatistician at the Toronto Center for Liver Disease and associate professor at the University of Toronto, said. “ThisRead More

Categories: News

Related Articles

CRC patients with unresectable liver metastases may benefit from living-donor LT

Living-donor liver transplantation may be a viable option for patients with unresectable, liver-confined colorectal cancer liver metastases, according to a study published in JAMA Surgery.“This…

Statins may protect against acute cholangitis in primary sclerosing cholangitis

SAN DIEGO — Statin therapy decreased the risk for developing acute cholangitis among patients with primary sclerosing cholangitis, according to research presented at Digestive Disease…

Let’s Talk About Physician Burnout

Physician Burnout has become a serious topic of discussion in the healthcare field lately. With such a large array of factors affecting the well-being…

Justin Bouck June 5, 2018

VIDEO: Stelara can safely be used long-term to benefit patients with UC, Crohn’s

In a Healio video exclusive, Remo Panaccione, MD, discusses results from long-term, pooled analyses of adult patients treated with ustekinumab for inflammatory bowel disease.“We know…

Low-carbohydrate, high-fat diet reduced fatty liver, improved type 2 diabetes control

LONDON — A low-carbohydrate, high-fat diet significantly improved nonalcoholic fatty liver disease activity score and HbA1c more than a high-carbohydrate, low-fat diet in people with…